« VivaGel ™’s Clinical Development IND for Prevention of Genital Herpes Cleared by USFDA | Main | PhosLo® (calcium acetate) Demonstrated Superior Serum Phosphorus Control Over Sevelamer »

Jul24
Warning on Dangers of Excess Acetaminophen, Issued by the American Liver Foundation

The American Liver Foundation (ALF) recently issued a warning based on a recent study on the effects of high doses of the popular pain reliever acetaminophen on one’s liver.

The recent study (published in the Journal of the American Medical Association, JAMA) showed that healthy adults who took the maximum recommended dose of acetaminophen for two weeks had drastically increased liver enzyme levels which could lead to liver damage.

"The American Liver Foundation recommends that people not exceed three grams of acetaminophen a day for any prolonged period of time as recently demonstrated in the JAMA article," said Dr. James Boyer, chairman of the board of directors of the American Liver Foundation.

"This is the equivalent of six 'extra-strength' tablets a day for several weeks. Regular, short-term use of the product is not an issue. Anyone currently suffering from liver disease should check with their physician or hepatologist before taking acetaminophen."

The following are already known about Liver Disease:

  • The liver is one of the body's largest organs, performing hundreds of functions every day. It removes harmful substances from the blood, make bile to help digest fat, and stores energy.
  • 30 million Americans - one in every 10 - are or have been affected by a liver, biliary, or gallbladder disease.
  • Liver disease and cirrhosis are the 7th leading cause of death among adults between the ages of 25 and 64 in the U.S.
  • Many forms of liver disease are preventable, and many more, if detected early, can be treated effectively.

Acetaminophen (a key ingredient to such well-known brands as Tylenol and Vicodin) is contained in over 200 over-the-counter (OTC) in various forms.

Acute liver failure caused by excess acetaminophen has risen to from 28% of all cases in 1998 to 51% in 2003.

Source: PR Newswire

related entries


0 Comments/Trackbacks




submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« VivaGel ™’s Clinical Development IND for Prevention of Genital Herpes Cleared by USFDA | Main | PhosLo® (calcium acetate) Demonstrated Superior Serum Phosphorus Control Over Sevelamer »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb